GL1X · GenesisL1 explorer

Research workbench

The crystal structure of the anti-viral APOBEC3G catalytic domain

Analyse The crystal structure of the anti-viral APOBEC3G catalytic domain in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3E1U
Type
protein
Length
184 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA dc->du-editing enzyme apobec-3G
EC
3.5.4.-
UniProt
Q9HC16
Ligands
ZN
Pockets
2 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA dc->du-editing enzyme apobec-3G (EC 3.5.4.-)protein18436% helix, 20% strandQ9HC16

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11230.620.8520empty
2940.400.7721empty

Compared structures

  • 3E1U · The Crystal Structure of the Anti-Viral APOBEC3G Catalytic Domain · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9HC16 · AlphaFold monomer V2.0 prediction for DNA dc->du-editing enzyme apobec-3G (Q9HC16) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.